
Keywords: BIR; baculovirus inhibitor of apoptosis protein repeat; Bcl-2; B-cell lymphoma 2; CASP3; caspase-3; CASP9; caspase-9; CYC2; cytochrome c; DMEM; Dulbecco's Modified Eagle Medium; FBS; fetal bovine serum; HCC; human hepatocellular carcinoma; HPRT1; hypoxant